Therapeutics and Clinical Risk Management (Nov 2019)

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review

  • Yasuda Y,
  • Nagano T,
  • Tachihara M,
  • Chihara N,
  • Umezawa K,
  • Katsurada N,
  • Yamamoto M,
  • Sekiguchi K,
  • Kobayashi K,
  • Nishimura Y

Journal volume & issue
Vol. Volume 15
pp. 1283 – 1289

Abstract

Read online

Yuichiro Yasuda,1 Tatsuya Nagano,1 Motoko Tachihara,1 Norio Chihara,2 Kanoko Umezawa,1 Naoko Katsurada,1 Masatsugu Yamamoto,1 Kenji Sekiguchi,2 Kazuyuki Kobayashi,1 Yoshihiro Nishimura1 1Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan; 2Division of Neurology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, JapanCorrespondence: Tatsuya NaganoDivision of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Kobe, Hyogo 650-0017, JapanTel +81-783-82-5660Fax +81-783-82-5661Email [email protected]: We herein report the case of a 39-year-old Japanese female with eosinophilic pneumonia associated with natalizumab. The patient with bronchial asthma had multiple sclerosis and was treated using natalizumab. The patient was referred to our department because of a persistent cough. A chest computed tomography (CT) scan revealed bilateral patchy consolidation surrounded by ground-glass opacity. A bronchoalveolar lavage (BAL) was performed. Eosinophil levels in the BAL fluid were increased and the patient was consequently diagnosed as eosinophilic pneumonia associated with natalizumab. Therefore, natalizumab treatment was discontinued. Subsequent chest CT findings showed a remarkable improvement without any treatment.Keywords: eosinophilic pneumonia, natalizumab, multiple sclerosis

Keywords